Who Would I Consider for Capsule Endoscopy? – Part I

The advent of capsule endoscopy (CE) has been changing the paradigms of gastrointestinal (GI) evaluations ever since it was granted approval by the Food and Drug Administration in 2001. Over the past five years, significant changes have occurred in numerous areas, particularly with the assessment of the small intestine. As familiarity and availability have increased, endoscopic indications also seem to have expanded. Additionally, with new technology emerging (ie, Olympus capsule [Olympus Corporation, Tokyo, Japan], double balloon enteroscopy, esophageal and colonic capsules), these changes in management will continue to evolve and educational updates are critical (for physicians, patients and regulatory bodies) to maintain an appropriate high standard of care.